Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials

BACKGROUND: Hyperglycemia and hypercholesterolemia are class effects of mammalian target of rapamycin inhibitors. The purpose of this study was to characterize safety and efficacy of patients with metastatic renal cell carcinoma (mRCC) treated with everolimus in RECORD-1 (REnal Cell cancer treatment...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Genitourin Cancer
Main Authors: Bono, Petri, Oudard, Stephane, Bodrogi, Istvan, Hutson, Thomas E., Escudier, Bernard, Machiels, Jean-Pascal, Thompson, John A., Figlin, Robert A., Ravaud, Alain, Basaran, Mert, Porta, Camillo, Bracarda, Sergio, Brechenmacher, Thomas, Lin, Chinjune, Voi, Maurizio, Grunwald, Viktor, Motzer, Robert J.
格式: Artigo
語言:Inglês
出版: Elsevier 2016
主題:
Original Study
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063024/
https://ncbi.nlm.nih.gov/pubmed/27287020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2016.04.011
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍